tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Revenue

Compare
2,308 Followers

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had a revenue of 259.60M in the quarter ending Dec 31, 2024, with 3.67%. This bring the company's revenue in the last twelve months to 957.80M, Decreased 3.07%. In the fiscal year ending Dec 31, 2024, ACADIA Pharmaceuticals had annual revenue of 957.80M with 31.85% growth.
Revenue (ttm)
957.80M
Revenue Growth
31.85%
P/S Ratio
2.58
Revenue/Employee
$1,466,764
Employees
653
Market Cap
$2.47B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024957.80M231.36M+31.85%
Dec 31, 2023726.44M209.20M+40.45%
Dec 31, 2022517.24M33.09M+6.83%
Dec 31, 2021484.14M42.39M+9.60%
Dec 31, 2020441.75M102.68M+30.28%
Dec 31, 2019339.08M115.27M+51.50%
Dec 31, 2018223.81M98.91M+79.19%
Dec 31, 2017124.90M107.57M+620.68%
Dec 31, 201617.33M17.27M+28,311.48%
Dec 31, 201561.00K-59.00K-49.17%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis